# Welsh Lib Dems Pass Motion to Protect Medical Cannabis Patients > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medical-cannabis-patient-protections-wales/ > **Published:** 2026-04-14T13:08:33-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:22:18-04:00 > **Clinical Summary:** Welsh Lib Dems advance medical cannabis patient protections, signaling potential policy changes to improve access and reduce barriers for patients in Wales. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyAccess[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Healthcare SystemsPatient Advocacy Why This Matters Political advocacy for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patient protections directly impacts clinical accessibility and treatment continuity. When political parties formally support patient protections, it signals potential policy changes that could reduce barriers to evidence-based cannabis therapeutics. Clinical Summary The Welsh Liberal Democrats have passed a motion supporting protections for medical cannabis patients, though specific policy details are not provided in the available summary. This represents political momentum toward addressing access barriers that currently affect patients with qualifying conditions in Wales. Such motions typically address issues like prescription access, legal protections, and healthcare system integration. Dr. Caplan’s Take “Political support is encouraging, but patients need concrete policy changes, not just motions. What matters is whether this translates into actual prescribing pathways and reduced bureaucratic obstacles for clinicians.” Clinical Perspective 🧠 Clinicians should monitor whether this political support leads to practical changes in prescribing guidelines or patient access protocols. Patients in Wales may benefit from staying informed about evolving policy landscapes while continuing to work within current legal frameworks for [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/). 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Welsh%20Lib%20Dems%20pass%20motion%20to%20protect%20medical%20cannabis%20patients%20-%20leafie%20%40drcaplan&url=https%3A//www.leafie.co.uk/news/welsh-liberal-democrats-motion-protect-medical-cannabis-patients/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.leafie.co.uk/news/welsh-liberal-democrats-motion-protect-medical-cannabis-patients/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Welsh%20Lib%20Dems%20pass%20motion%20to%20protect%20medical%20cannabis%20patients%20-%20leafie%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.leafie.co.uk/news/welsh-liberal-democrats-motion-protect-medical-cannabis-patients/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.leafie.co.uk/news/welsh-liberal-democrats-motion-protect-medical-cannabis-patients/](https://www.leafie.co.uk/news/welsh-liberal-democrats-motion-protect-medical-cannabis-patients/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What type of cannabis-related content does this article cover?](#What_type_of_cannabis-related_content_does_this_article_cover) - [Who is the target audience for this information?](#Who_is_the_target_audience_for_this_information) - [Why is this considered “notable clinical interest”?](#Why_is_this_considered_8220notable_clinical_interest8221) - [What should healthcare professionals do with this information?](#What_should_healthcare_professionals_do_with_this_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has received CED Clinical Relevance #76 with a “Notable Clinical Interest” designation. This indicates emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What type of cannabis-related content does this article cover? The article focuses on policy developments and access issues related to medical cannabis. It appears to discuss healthcare system implications based on the categorization tags. #### Who is the target audience for this information? This content is primarily targeted at healthcare professionals and clinicians working with medical cannabis patients. The CED Clinical relevance rating system suggests it’s designed for medical practitioners who need to stay updated on cannabis policy and access developments. #### Why is this considered “notable clinical interest”? The notable clinical interest designation suggests this involves emerging policy or access developments that could impact patient care. Healthcare providers should monitor these developments as they may affect treatment options or patient access to medical cannabis. #### What should healthcare professionals do with this information? Healthcare professionals should monitor these developments closely as indicated by the clinical relevance rating. The information may impact how they approach [medical cannabis treatment](https://cedclinic.com/medical-cannabis-eligibility-book-appointment/) decisions or patient counseling regarding access and policy changes. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Idaho Medical Marijuana Advocates Collect Over 100,000 Signatures – Sun Valley Today](https://cedclinic.com/idaho-medical-marijuana-legalization-gains-momentum/) Learn how advocacy efforts in Idaho are shaping [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) access and patient protections. [Read More](https://cedclinic.com/idaho-medical-marijuana-legalization-gains-momentum/) [Justice Department Reclassifies State-Licensed Medical Marijuana](https://cedclinic.com/justice-department-medical-marijuana-reclassification/) Explore recent federal policy shifts impacting medical cannabis classification and patient access. [Explore Details](https://cedclinic.com/justice-department-medical-marijuana-reclassification/) [Medical Cannabis Prescription: Patient Guide | Hanf Magazin](https://cedclinic.com/medical-cannabis-patient-guide-prescription-access/) A comprehensive guide for patients navigating medical cannabis prescriptions and legal protections. [Learn More](https://cedclinic.com/medical-cannabis-patient-guide-prescription-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).